Intermediate hepatocellular carcinoma: the role of transarterial therapy.

@article{Chegai2015IntermediateHC,
  title={Intermediate hepatocellular carcinoma: the role of transarterial therapy.},
  author={Fabrizio Chegai and Antonio N. Orlacchio and Stefano Merolla and Serena Monti and Lorenzo Mannelli},
  journal={Hepatic oncology},
  year={2015},
  volume={2 4},
  pages={399-408}
}
According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20% with a 2-year survival of approximately 50%. Nowadays, transarterial therapies have proved precious in the treatment… CONTINUE READING